1. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
2. Joensuu H, Pylkkänen L, Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 1994;145:1191-1198.
3. Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival
4. Yuan RW, Ding Q, Jiang HY, Qin XF, Zou SQ, Xia HS. Bcl-2, P53 protein expression and apoptosis in pancreatic cancer. Shijie Huaoren Xiaohua Zazhi 1999;7:851-854.
5. Mäkinen K, Hakala T, Lipponen P, Alhava E, Eskelinen M. Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma. Anticancer Res 1998;18:615-618.